Medical Cannabis News

Warning message

The subscription service is currently unavailable. Please try again later.
Synonyms: 
mmj
Mon
20
Dec

Regular Marijuana Use May Lead to Sleep Problems

insomnia

A new study found that frequent intake of cannabis may increase the likelihood a person will sleep too little or too much.

Although some people turn to cannabis as a sleep aid because it makes them drowsy and relaxed, a large new study shows that marijuana may interfere with proper rest, especially if you’re a heavy user.

Mon
20
Dec

Why do people use cannabis during pregnancy and breastfeeding?

pregnant woman

People who use cannabis during pregnancy and lactation choose it to manage pregnancy-related symptoms and pre-existing conditions, such as nausea and vomiting, mental health problems, insomnia and more, according to new research published in CMAJ (Canadian Medical Association Journal).

Fri
17
Dec

Australia Rejects Psychedelics for Therapeutic Use

australia

 

Counter to the overall trend in support of psychedelic research, Australia will not approve psychedelics for therapeutic use.

Australia’s medical regulator on Wednesday rejected a bid to approve psychedelics for therapeutic use, saying the risks of the drugs outweigh the potential mental health benefits. In a final decision from the Therapeutic Goods Administration (TGA), the agency declined to approve an application to amend Australia’s poison standards by reclassifying psilocybin and MDMA as Schedule 8 controlled substances instead of their current status as prohibited substances under Schedule 9.

Mon
13
Dec

"The New Cannabis" – the present and future of psilocybin as a medical treatment in Canada

gloved hand

WeirFoulds' Dana Kriszenfeld on loosening the regulations on psychedelic mushrooms' main ingredient

Psilocybin is the active ingredient found in magic mushrooms, which many refer to as the "new cannabis". As interest in this substance grows, Canada’s capital markets have seen an increase in activity related to psilocybin from both public companies and investors. Proponents cite research demonstrating psilocybin’s potential as a treatment for various mental illnesses. While the research in this area is optimistic, psilocybin remains a heavily regulated substance in Canada. Here, we outline the current situation in Canada for psilocybin and offer thoughts on the future of this emerging industry. 

Thu
09
Dec

Strange Side Effects of Marijuana, Says Science

old woman smoking up

According to medical experts, the following side effects can happen when smoking marijuana.

Mon
06
Dec

Essential guide to understanding cannabis concentrates

cannabis

Flower normally has a THC content that ranges from 10 per cent to 25 percent, but concentrated products in the U.S. can exceed 80 per cent.

As the marijuana business continues to grow, the methods of weed consumption seem to evolve just as quickly. Flower cannabis represents only a small portion of most dispensary retail operations in the U.S. And as time goes on, concentrates are becoming more popular and diverse.

As this niche market begins to outsell other marijuana products, it is important to understand exactly what marijuana concentrates are.

Thu
02
Dec

Manitoba Harvest Introduces Hemp Hearts Health Hack to Thrive During the Holidays

cannabinoid

78% of People Surveyed Want More Holistic Health Support This Season

Manitoba Harvest, a leading hemp food manufacturer and pioneer in the natural foods industry and a wholly owned subsidiary of Tilray, Inc., introduces a hemp hearts health hack in time for the holidays. As many people jump back into previously paused holiday traditions, it’s important to remember that while this time of year can be joyous, it can also be extremely tiring and stressful. This makes it even more critical to build in simple practices supportive of healthy eating, while still enjoying favorite traditions.

Thu
25
Nov

Cannabis drug trial for brain tumours, backed by Olympian Tom Daley, secures research funding

brain scan x-rays

The phase II trials of cannabis-based drug Sativex in treating the most aggressive form of form of brain cancer will begin in early 2022.

Following a phase I trial that demonstrated promising results in treating the most aggressive form of brain cancer with a cannabis-based drug, phase II trials are set to begin in March 2022.

The trial will build on previous research in treating recurrent glioblastoma with chemotherapy and Sativex, an oral spray containing 1:1 tetrahydrocannabinol (THC) and cannabidiol (CBD).

Wed
24
Nov

Chronic cannabis smoking associated with central nervous system abnormalities

person smoking joint

Findings from the study conducted on mice “may help develop novel treatments for prevention of some neurological abnormalities.”

New research out of the U.S. suggests the saliva microbiome of chronic weed smokers with cannabis use disorder could be associated with central nervous system (CNS) abnormalities that can affect the brain, spinal cord, and nerves found throughout the body.

A microbiome relates to the microorganisms in a particular environment. In the case of saliva, it comprises bacteria shed from oral surfaces.

Fri
19
Nov

How Crohn's Disease Opened My Eyes To The Healing Properties Of Cannabis

woman holding stomach

Many founders of cannabis companies have origin stories about how the powerful plant changed their lives – from enhanced intimacy and increased focus to better performance in sports and better sleep. I, however, do not have the same story. In fact, I was never really interested in cannabis and was somewhat of a reluctant participant.

Pages

Subscribe to RSS - Medical Cannabis News